Akebia Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AKBA and other ETFs, options, and stocks.

About AKBA

Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders. 

CEO
John P. Butler
CEOJohn P. Butler
Employees
194
Employees194
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2007
Founded2007
Employees
194
Employees194

AKBA Key Statistics

Market cap
241.33M
Market cap241.33M
Price-Earnings ratio
-7.79
Price-Earnings ratio-7.79
Dividend yield
—
Dividend yield—
Average volume
5.90M
Average volume5.90M
High today
$0.8886
High today$0.8886
Low today
$0.84
Low today$0.84
Open price
$0.888
Open price$0.888
Volume
7.10M
Volume7.10M
52 Week high
$3.20
52 Week high$3.20
52 Week low
$0.814
52 Week low$0.814

Stock Snapshot

As of today, Akebia Therapeutics(AKBA) shares are valued at $0.86. The company's market cap stands at 241.33M, with a P/E ratio of -7.79.

On 2026-10-03, Akebia Therapeutics(AKBA) stock moved within a range of $0.84 to $0.89. With shares now at $0.86, the stock is trading +2.5% above its intraday low and -3.1% below the session's peak.

Trading volume for Akebia Therapeutics(AKBA) stock has reached 7.1M, versus its average volume of 5.9M.

The stock's 52-week range extends from a low of $0.81 to a high of $3.20.

The stock's 52-week range extends from a low of $0.81 to a high of $3.20.

Analyst ratings

83%

of 6 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

People also own

Based on the portfolios of people who own AKBA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.